Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hodgkin's or Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00121186
What this trial is testing

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 1
Testing effectiveness (Phase 2)Study completedNCT01466153
What this trial is testing

A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
MedImmune LLC 183
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07819188
What this trial is testing

SCTB35 and SCTB41 With or Without Chemotherapy in Non-Hodgkin Lymphoma

Who this might be right for
NHL - Non-Hodgkin's Lymphoma
Sinocelltech Ltd. 90
Not applicableEnded earlyNCT00038779
What this trial is testing

Blood Transplantation for Patients With Hematologic Malignancies or Bone Marrow Failure States

Who this might be right for
LeukemiaNon Hodgkin's LymphomaAplastic Anemia
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)Study completedNCT00770224
What this trial is testing

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
SWOG Cancer Research Network 87
Early research (Phase 1)Study completedNCT05149391
What this trial is testing

C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma

Who this might be right for
B Cell Non-Hodgkin's Lymphoma
Peking University 3
Testing effectiveness (Phase 2)Study completedNCT00062296
What this trial is testing

Epirubicin and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Fox Chase Cancer Center 5
Testing effectiveness (Phase 2)Looking for participantsNCT05623982
What this trial is testing

GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Non-hodgkin's Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)Study completedNCT02226965
What this trial is testing

PNT2258 for Treatment of Patients With r/r DLBCL (Wolverine)

Who this might be right for
Lymphoma, Diffuse Large B-Cell
Sierra Oncology LLC - a GSK company 45
Testing effectiveness (Phase 2)Ended earlyNCT02361346
What this trial is testing

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Who this might be right for
Non-Hodgkin's B-cell LymphomaLeukemia, Lymphocytic, Chronic, B-CellSmall Lymphocytic Leukemia+3 more
Molecular Templates, Inc. 38
Early research (Phase 1)UnknownNCT05758610
What this trial is testing

A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients

Who this might be right for
NHL, AdultAML, Adult Recurrent
Shengke Pharmaceuticals (Jiangsu) Limited, China 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03533283
What this trial is testing

An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkins Lymphoma
Hoffmann-La Roche 211
Not applicableEnded earlyNCT00038818
What this trial is testing

CD8 DLI for Patients With Relapse or Residual Disease Following Allogeneic Stem Cell Transplantation

Who this might be right for
Chronic Myelogenous LeukemiaMultiple MyelomaNon Hodgkin's Lymphoma+2 more
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT02037256
What this trial is testing

Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Adult Burkitt Lymphoma+86 more
Barbara Ann Karmanos Cancer Institute 23
Large-scale testing (Phase 3)Study completedNCT00312845
What this trial is testing

Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Millennium Pharmaceuticals, Inc. 676
Testing effectiveness (Phase 2)Active Not RecruitingNCT05950165
What this trial is testing

Assess Safety and Efficacy of CHO-H01 as a Single Agent/Combined With Lenalidomide in Subjects With Refractory or Relapsed Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Cho Pharma Inc. 37
Not applicableStudy completedNCT00098566
What this trial is testing

Long-Term Effects of Iodine I Tositumomab and Autologous Bone Marrow or Stem Cell Transplantation in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaQuality of Life
Fred Hutchinson Cancer Center 36
Early research (Phase 1)Study completedNCT00389051
What this trial is testing

A Phase I Study of Bendamustine Hydrochloride in Patients With Indolent B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
SymBio Pharmaceuticals 9
Testing effectiveness (Phase 2)Study completedNCT00002494
What this trial is testing

Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Alliance for Clinical Trials in Oncology 134
Next Page